All News Ipca Laboratories Limited Bombay S.E.

Equities

IPCALAB

INE571A01038

Market Closed - Bombay S.E. Other stock markets 06:00:53 2024-07-16 am EDT			5-day change	1st Jan Change
1,218 ^INR	-0.77%		-0.27%	+9.40%

Jul. 11	Ipca Laboratories Limited Announces Superannuation of Dr. Goutam Muhuri as President R&D (Formulations)	CI
May. 30	Transcript : Ipca Laboratories Limited, Q4 2024 Earnings Call, May 30, 2024

All News

Unlock all the news: Be the first to know and act before the market!

100% Free Registration

Ipca Laboratories Limited Announces Superannuation of Dr. Goutam Muhuri as President R&D (Formulations)	Jul. 11	CI
Transcript : Ipca Laboratories Limited, Q4 2024 Earnings Call, May 30, 2024	May. 30
Ipca Laboratories Limited Reports Earnings Results for the Fourth Quarter and Full Year Ended March 31, 2024	May. 29	CI
Ipca Laboratories Limited Recommends Final Dividend for the Financial Year Ended March 31, 2024	May. 29	CI
Makers Laboratories Gets Board Nod to Sell Mumbai, India Property to Ipca Laboratories	May. 23	MT
Ipca Laboratories Limited Announces Cessation of Anand T. Kusre as an Independent Director	Mar. 29	CI
Ipca Laboratories Limited Appoints Swati Arvind Patankar as an Independent Director	Mar. 29	CI
Ipca Laboratories Licenses Anti-Cancer Biosimilar Technology to Omexa Formulary	Mar. 27	MT
Ipca Laboratories Limited Enters into A Technology Transfer Agreement with Omexa Formulary Pvt. Ltd	Mar. 27	CI
Nomura Adjusts IPCA Laboratories Price Target to INR1,308 From INR1,113, Keeps at Buy	Feb. 19	MT
Transcript : Ipca Laboratories Limited, Q3 2024 Earnings Call, Feb 15, 2024	Feb. 15
Ipca Laboratories Limited Announces Appointment of Kamal Kishore Seth as the Lead Independent Director	Feb. 14	CI
Ipca Laboratories Limited Reports Earnings Results for the Third Quarter and Nine Months Ended December 31, 2023	Feb. 14	CI
Ex-dividend day for interim dividend	Nov. 21	FA
Transcript : Ipca Laboratories Limited, Q2 2024 Earnings Call, Nov 10, 2023	Nov. 10
Ipca Laboratories Limited Declares Interim Dividend for the Financial Year 2023-24	Nov. 10	CI
Ipca Laboratories Limited Reports Earnings Results for the Second Quarter and Six Months Ended September 30, 2023	Nov. 10	CI
Ipca Laboratories' Pithampur Plant Classified as VAI by US FDA	23-10-31	MT
Nomura Upgrades Ipca Laboratories to Buy From Neutral, Adjusts Price Target to INR1,133 From INR942	23-10-23	MT
INDIA STOCKS-Indian shares slide on Mideast jitters; ICICI Bank up on earnings beat	23-10-23	RE

No results for this search

All News Analyst Reco. Highlights Insiders Transcripts Press Releases Official Publications Other languages Trading Ideas MarketScreener Editorial Features MarketScreener Strategies

All News Ipca Laboratories Limited Bombay S.E.

Equities

IPCALAB

INE571A01038

All News

Filters